Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JACC. Asia|November 29, 2022
Effect of Atorvastatin on Serial Changes in Coronary Physiology and Plaque ParametersCheol Hyun Lee, Jongmin Hwang, In-Cheol Kim, et al.
Korean Circulation Journal|March 17, 2025
Safety and Performance of the Micra VR Leadless Pacemaker in a South Korean Cohort: A Comparison to Global StudiesMyung-Jin Cha, Seung-Jung Park, Youngjin Cho, et al.
Thrombosis and Haemostasis|November 20, 2015
Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trialJeong-Su Kim, Dong-Cheul Han, Young-Hoon Jeong, et al.
Journal of Korean Medical Science|October 12, 2020
The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019In Cheol Kim, Jin Eun Song, Hee Jung Lee, et al.
American Heart Journal|February 12, 2022
Edoxaban-based long-term antithrombotic therapy in patients with atrial fibrillation and stable coronary disease: Rationale and design of the randomized EPIC-CAD trialMin Soo Cho, Do-Yoon Kang, Yong-Seog Oh, et al.
Korean Circulation Journal|March 17, 2025
Comparison of Thick Biolimus A9-Eluting Stent and Thin Zotarolimus-Eluting Stent in Multi-Vessel Percutaneous Coronary InterventionCheol Hyun Lee, Hee Jeong Lee, Tae-Wan Chung, et al.
Heart (British Cardiac Society)|September 10, 2025
Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trialMin Soo Cho, Do-Yoon Kang, Jung-Bok Lee, et al.
JACC. Asia|February 28, 2026
Sex-Based Differences in Clinical Outcomes With Edoxaban Therapy: A Prespecified Analysis of the EPIC-CAD TrialGi-Hwan Kim, MinSoo Cho, Seonok Kim, et al.
The New England Journal of Medicine|September 3, 2024
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery DiseaseMin Soo Cho, Do-Yoon Kang, Jung-Min Ahn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 20, 2026
Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trialJoong Min Lee, Min Soo Cho, Do-Yoon Kang, et al.
Pageof 6